Drugs / Oxycodone/naloxone
last change Jun 2014 re-read 3 minutes ago

Oxycodone/naloxone

Developed for
chronic pain syndrome
Investigated by
Mundipharma Korea Ltd

Trials 1

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01811186 Dec 2012 → Jan 2014 chronic pain syndrome Mundipharma Korea Ltd Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Oxycodone/naloxone ClinicalTrials.gov intervention name — accepted as the source's own label NCT01811186 ↗